Following that, the remaining PXA cases without BRAFV600E (including our patient) have been reported to harbor RTK (receptor tyrosine kinase) gene fusions rather than MAPK(mitogen-activated protein kinase) alterations (34). This evidence concerns the gene WNK2 and pleomorphic xanthoastrocytoma.